on 28 Oct 2024
Last Applicant/ Owned by
Novartis AG
CH-4002 Basel
CH
Serial Number
2220017 filed on 11th Oct 2022
Correspondent Address
SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO
ONTARIO
CA
M5H3Y2
Trademark usage description
pharmaceutical preparations for the prevention and treatment of the central nervous system, namely central nervous system infections, brain diseases, Read More9
2220017
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 22 on 19th Feb 2024 | Search Recorded |
Submitted for opposition 20 on 19th Feb 2024 | Examiner's First Report |
Submitted for opposition 223 on 19th Feb 2024 | Total Provisional Refusal |
Submitted for opposition 256 on 05th Sep 2023 | Notification of Possible Opposition Sent |
Submitted for opposition 257 on 03rd Nov 2022 | Designation Notification - Madrid Protocol |
Submitted for opposition 31 on 03rd Nov 2022 | Formalized |
Submitted for opposition 1 on 03rd Nov 2022 | Created |
Submitted for opposition 30 on 11th Oct 2022 | Filed |
Submitted for opposition 238 on 04th Jul 2018 | IR Renewed |
Submitted for opposition 228 on 04th Jul 2008 | International Registration |